Stocktoria
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB
Nasdaq · XNAS · stock · Laboratory Analytical Instruments · website · IPO 2010-10-27
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $160.0M | $154.0M | $200.5M | $128.3M | $130.5M |
| Gross profit | $45.8M | $37.3M | $52.8M | $49.0M | $58.9M |
| R&D expense | $97.3M | $134.9M | $187.2M | $193.0M | $112.9M |
| SG&A expense | $141.5M | $175.0M | $169.8M | $160.9M | $124.1M |
| Operating income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M |
| Interest expense | — | — | $14.3M | $14.7M | $12.5M |
| Income tax | $318,000 | $316,000 | -$11.4M | $0 | -$93.6M |
| Net income | -$546.4M | -$309.9M | -$306.7M | -$314.2M | -$181.2M |
| EPS (diluted) | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 |
| Operating cash flow | -$111.2M | -$206.1M | -$259.2M | -$263.2M | -$111.2M |
| Free cash flow | -$113.9M | -$212.2M | -$268.0M | -$280.0M | -$117.1M |
| Cash & equivalents | $63.7M | $55.4M | $179.9M | $325.1M | $460.7M |
| Inventory | $49.3M | $58.8M | $56.7M | $50.4M | $24.6M |
| Total assets | $784.1M | $1.3B | $1.7B | $1.8B | $2.0B |
| Total liabilities | $778.7M | $753.9M | $1.0B | $1.2B | $1.2B |
| Shareholders' equity | $5.3M | $506.6M | $701.3M | $562.9M | $791.0M |
Source: SEC EDGAR filings · CIK 0001299130 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.